
FDA approves much-debated Alzheimer's drug panned by experts
India Today
The decision, which could impact millions of older Americans and their families, is certain to spark disagreements among physicians, medical researchers, and patient groups.
Government health officials on Monday approved the first new drug for Alzheimer's disease in nearly 20 years, disregarding warnings from independent advisers that the much-debated treatment hasn't been shown to help slow the brain-destroying disease. The Food and Drug Administration said it granted approval to the drug developed by Biogen for patients with Alzheimer's disease. It's the only drug that U.S. regulators have said can likely treat the underlying disease, rather than manage symptoms like anxiety and insomnia.
Oil and gas refineries and hubs are up in flames not just in the Middle East, but also in Russia and the US. Crude oil prices have surged over $100 a barrel. With the energy infrastructure in the Middle East likely to take years to be rebuilt, the world could be set for the biggest oil disruption in history.

Speaking at the White House, Trump said the United States was in contact with "the right people" in Iran and suggested that Tehran was eager to reach an agreement to halt hostilities. "We're in negotiations right now," he told reporters, without offering further details on the scope or format of the talks.











